Stay updated on Sepofarsen Safety in Children Clinical Trial

Sign up to get notified when there's something new on the Sepofarsen Safety in Children Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sepofarsen Safety in Children Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study details, eligibility criteria, recruiting locations, and outcome measures appear unchanged.
    Difference
    0.1%
    Check dated 2026-11-14T13:58:07.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The BRIGHTEN study record for sepofarsen in children with LCA10 is displayed, including its study plan, eligibility requirements, outcome measures, and contact and location details.
    Difference
    68%
    Check dated 2026-11-07T13:43:49.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T14:53:37.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the study page’s 403 error.
    Difference
    1%
    Check dated 2026-10-24T14:07:22.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:03:01.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T15:51:53.000Z thumbnail image

Stay in the know with updates to Sepofarsen Safety in Children Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sepofarsen Safety in Children Clinical Trial page.